Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The timing of today’s PR and the one from 2 weeks ago is very important, imho.
“Multiple pathways”
-Dave Innes (investor relations)
Wow. Today’s announcement is a huge endorsement by Dr Linda Liau.
There’s a buzz about $NWBO in Northern Canada pic.twitter.com/UziEGfUaur
— Michael Bigger (@biggercapital) September 12, 2023
Crickets from Ex as usual when presented with actual facts. :)
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
“Breakthrough”, “Astonishing”, and “Game-changing” is how the trial results have been described by the real experts (see links below). Compare that to anonymous message board poster opinions. :)
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
It’s been awhile since I read the Complaint. Thanks for the reminder!
It occurred to me that if NWBO’s counsel can show, based on trading data, that the defendants have continued to spoof since the Complaint was filed/served, then punitive damages may be permitted. NWBO would need to amend the Complaint to include punitives and the basis but it would certainly make sense. Punitive damages are intended punish and deter the same type of behavior. I cannot think of a more appropriate situation for punitive damages if the illegal action has been continuing.
Was there a pending lawsuit alleging egregious market manipulation at the time? There is here, and other entities are likely watching and recording the trading activity here. :)
“Astonishing”, “ breakthrough”, and “game-changing” are just a few terms used by the real experts (not anonymous message board posters) to describe DCVAX-L. Commercial approval and patient access coming very soon!
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
No real lawyer will take your imaginary case. Give me his/her contact info and I’ll be happy to provide the MTD you filed in the FL case. That will provide some guidance. ;)
Shall I post the link to the FL court public docket where you were sued (as the handle Poorman) for your stock price manipulation message board activities?
Precisely. Interesting that he’s back posting tonight….
Not my article but I find the citations vey very persuasive. The author did a fantastic job of providing references, screenshots and citations.
I agree with you re: the judge’s inclination to deny the MTD swiftly after reading the briefs submitted to-date.
“This personalized immune therapy could be a game-changer for a disease that is so deadly and difficult to treat,” said Walter. “For the first time in 20 to 30 years, there is hope to meaningfully extend patients’ lives.”
https://www.urmc.rochester.edu/news/story/personalized-immune-therapy-extended-survival-in-patients-with-aggressive-brain-cancer
“Breakthrough” results according to real life experts. Compare that to anonymous message board poster comments like yours. ;)
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
Then maybe his post is still up. I just don’t really have time, nor the desire, to look. It’s a holiday weekend after all :)
I’ll likely be adding more as well. Application for commercial approval will likely be submitted THIS MONTH. Sit back, enjoy a nice beverage, and think about that. It’s been a long road but we’re at the end. Really incredible stuff.
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
Crickets, as expected. You are absolutely correct that his narrative for a long time was the data would never be published in a legitimate medical journal and that they would never file for approval. In fact, a few days before the JAMA peer reviewed article was published he posted on this board that they would be lucky to be published in Southern Living (or something similar). He deleted the post but I think I took a screenshot. I’ll go back and look. :)
WOW the FUDsters are working overtime this weekend. What’s the motivation?? Makes one think another PR may drop this week.
Yea, it means the treatment works even better in patients that don’t typically respond well to treatment. You need a lesson in reading comprehension. Do you know what “breakthrough” means? Are you familiar with Brown University? :)
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
“Astonishing” results according to the experts.
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
Exactly.
Wow, posting in the early morning hours of a Sunday on a holiday weekend. What could provide such motivation?? I wonder….get some sleep, Ex.
Why is it that none of the FUD spreaders will respond to this post that cites the real experts? I’m talking about Ex, Learning Curve, Poorman, Legend, etc…..
cc: LearningCurve
“Breakthrough” and “astonishing” are the words used by the real experts to describe DCVAX-L. Compare that to the opinion of Exwannabe, an anonymous message board poster with a background in IT. I know who I believe. :)
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/
https://www.braintumourresearch.org/media/news/news-item/2022/11/18/astonishing-results-for-brain-tumour-vaccine-trial
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
Excellent point, as always. Factual and nothing more.
Approval this year. 95%+ chance according to the data. Short sellers and FUDsters are in serious trouble and they don’t have a way out. That’s why we are seeing the insane increase in FUD on this board. No other explanation makes sense.
Published today by UCLA:
Prins, who is also a researcher at the Jonsson Cancer Center, said that finding “suggests that enhancing the activation and presentation of T cells by dendritic cells could be a potential treatment strategy.”
https://www.uclahealth.org/news/why-certain-brain-tumors-dont-respond-to-immunotherapy
An expert will be hired by the Plaintiff on this issue. That expert will then provide an opinion on damages. Due to the fact that the case is in federal court, the expert will also generate a report, which provides his/her opinions and the basis for the opinions. We are a ways out from expert disclosures in this case.
Rolling review
Rolling review for marketing authorisation applications describes a new route for MA applications which aims to streamline the development of novel medicines. MA applications for any new active substance, based on a "full dossier’" including biological products, are eligible for the route. Biosimilars are also eligible. Under this procedure, applicants submit increments of the electronic common technical document (eCTD) dossier to the MHRA for pre-assessment rather than as part of a consolidated full dossier submission. The modular approach aims to reduce risk of failure at the final phase of the assessment.
Timetable
Assessment of the first module will start from Day 0 with the assessment cycle being completed within 60 days. Following each assessment cycle, a Module Assessment Summary (MAS) will be issued by Day 60. The MAS enables the applicant to update the module, and the updated modules should be included in the final phase.
The final phase should be completed within 100 days in two stages with a clock off period after 60 days. The MHRA may issue an RFI by Day 60 and applicants will be able to discuss any issues identified in the RFI with the MHRA within 30 days. The clock then resumes on Day 61 with the final decision on approvability reached by Day 100. Orphan status will be determined at the time of grant of the MA.
https://uk.practicallaw.thomsonreuters.com/w-029-1301?transitionType=Default&contextData=(sc.Default)